HeraMED Limited (1I4) - Cash Flow Conversion Efficiency
Based on the latest financial reports, HeraMED Limited (1I4) has a cash flow conversion efficiency ratio of 8.075x as of December 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-855.85K ≈ $-1.00 Million USD) by net assets (€-105.98K ≈ $-123.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1I4 company net worth for the company's overall valuation and market capitalisation.
HeraMED Limited - Cash Flow Conversion Efficiency Trend (2018–2021)
This chart illustrates how HeraMED Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
HeraMED Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HeraMED Limited ranked by their cash flow conversion efficiency. See 1I4 debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TT Vision Holdings Berhad
KLSE:0272
|
-0.018x |
|
HPP Holdings Bhd
KLSE:0228
|
0.034x |
|
Hankukpackage Co. Ltd
KQ:037230
|
0.048x |
|
AS Pro Kapital Grupp
F:17E
|
0.152x |
|
Bonava AB (publ)
ST:BONAV-A
|
-0.022x |
|
Senetas Corporation Ltd
AU:SEN
|
-0.024x |
|
Venteny Fortuna International
JK:VTNY
|
-0.027x |
|
Touch Ventures Ltd
AU:TVL
|
0.006x |
Annual Cash Flow Conversion Efficiency for HeraMED Limited (2018–2021)
The table below shows the annual cash flow conversion efficiency of HeraMED Limited from 2018 to 2021. View 1I4 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | €-105.98K ≈ $-123.91K |
€-3.23 Million ≈ $-3.78 Million |
30.493x | +2946.50% |
| 2020-12-31 | €2.59 Million ≈ $3.03 Million |
€-2.78 Million ≈ $-3.25 Million |
-1.071x | -38.01% |
| 2019-12-31 | €3.41 Million ≈ $3.98 Million |
€-2.65 Million ≈ $-3.09 Million |
-0.776x | -170.25% |
| 2018-12-31 | €6.15 Million ≈ $7.19 Million |
€-1.77 Million ≈ $-2.06 Million |
-0.287x | -- |
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more effic… Read more